Literature DB >> 9643803

Improvement in renal cholesterol emboli syndrome after simvastatin.

R G Woolfson, H Lachmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9643803     DOI： 10.1016/S0140-6736(05)79058-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Recurrent renal cholesterol embolism.

Authors:  W S Waring; R Fergusson; S Fleming
Journal:  J R Soc Med       Date:  1999-12       Impact factor: 5.344

2.  Lesson of the week: cholesterol emboli syndrome.

Authors:  P J Dupont; L Lightstone; E J Clutterbuck; G Gaskin; C D Pusey; T Cook; A N Warrens
Journal:  BMJ       Date:  2000-10-28

3.  Commentary: Iloprost for cholesterol emboli syndrome.

Authors:  Charles D Pusey
Journal:  BMJ       Date:  2002-03-09

Review 4.  Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention.

Authors:  R G Woolfson
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

5.  Low-density lipoprotein apheresis ameliorates monthly estimated glomerular filtration rate declines in patients with renal cholesterol crystal embolism.

Authors:  Keiji Hirai; Susumu Ookawara; Haruhisa Miyazawa; Kiyonori Ito; Yuichirou Ueda; Yoshio Kaku; Taro Hoshino; Izumi Yoshida; Kaoru Tabei
Journal:  J Artif Organs       Date:  2014-11-04       Impact factor: 1.731

6.  Efficacy of low-density lipoprotein apheresis combined with corticosteroids for cholesterol crystal embolism.

Authors:  Katsuya Ishiyama; Toshinobu Sato; Takuhiro Yamaguchi; Yoshio Taguma
Journal:  Clin Exp Nephrol       Date:  2016-04-21       Impact factor: 2.801

7.  Atheroembolism.

Authors:  John S. Smyth; John E. Scoble
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

8.  Progressive acute kidney injury following myocardial infarction: cholesterol embolisation.

Authors:  Malvinder S Parmar
Journal:  BMJ Case Rep       Date:  2009-02-23

9.  Cholestrol emboli syndrome: acute renal insufficiency after a procedure or a thrombolytic therapy or anticoagulant therapy.

Authors:  C Chandra Sekhar; Parveen Jindal; V Guru Karna; Manoj Aggarwala; Soma Sekhar
Journal:  Indian J Surg       Date:  2012-10-07       Impact factor: 0.656

10.  Favorable outcome in atheroembolic renal disease with pulse steroid therapy.

Authors:  A Sharma; R Hada; R K Agrawal; A Baral
Journal:  Indian J Nephrol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.